IT Home On May 20, it was reported by the Wall Street Journal on May 20 that the US Food and Drug Administration (FDA) approved Elon Musk's Neuralink Company to implant brain chips for the second patient, and approved the company's repair plan for the problems of the first subject.
According to insiders, after the approval of FDA, Neuralink now hopes to implant the chip into the brain of a second subject sometime in June. Neuralink aims to implant chips for 10 people this year, and hopes to have different subjects participate in order to study various behaviors. In addition, Neuralink hopes to submit an application to Canadian and British regulators in the coming months to carry out similar tests.
IT House noticed that Reuters reported last week that Neuralink disclosed that the first patient had loosening problems after chip implantation, which the company had already known. According to the Wall Street Journal, in order to solve this problem, Neuralink will implant some thinner probes into deeper locations.
Related reading:
《 Mask announced that the brain computer interface test began to recruit the second patient, and the first implant realized the idea control of the computer 》
Advertising statement: The external jump links (including but not limited to hyperlinks, QR codes, passwords, etc.) contained in the text are used to convey more information and save selection time. The results are for reference only. All articles of IT Home contain this statement.
